Liquidia Reports First Quarter 2022 Financial Results and Provides Corporate Update
May 12, 2022 07:00 ET
|
Liquidia Corporation
- Secured access to new capital through debt and equity transactions - Increased utilization of Treprostinil Injection with increasing payer generic mandates - Advanced Hatch-Waxman litigation in...
Liquidia to Report First Quarter 2022 Financial Results on May 12, 2022
May 05, 2022 08:00 ET
|
Liquidia Corporation
MORRISVILLE, N.C., May 05, 2022 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today that it will report its first quarter 2022 financial results on Thursday, May 12, 2022. The...
Liquidia Corporation Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
April 25, 2022 08:45 ET
|
Liquidia Corporation
MORRISVILLE, N.C., April 25, 2022 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) today announced the grant of inducement stock options exercisable for an aggregate of 35,700 shares of...
Liquidia Announces Oral Presentation at the 42nd Annual Meeting of International Society for Heart and Lung Transplant (ISHLT)
April 20, 2022 10:01 ET
|
Liquidia Corporation
MORRISVILLE, N.C., April 20, 2022 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) (“Liquidia” or the “Company”) today announced that Sandeep Sahay, MD, from Houston Methodist Hospital will...
Liquidia Announces Closing of Public Offering of Common Stock and Full Exercise of Over-Allotment Option
April 18, 2022 16:05 ET
|
Liquidia Corporation
MORRISVILLE, N.C., April 18, 2022 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) (“Liquidia”) today announced the closing of its previously announced underwritten public offering of...
Liquidia Announces Pricing of Public Offering of Common Stock
April 12, 2022 21:38 ET
|
Liquidia Corporation
MORRISVLLE, N.C., April 12, 2022 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) (“Liquidia”) announced the pricing of an underwritten public offering of 9,803,922 shares of its common stock...
Liquidia Announces Proposed Offering of Common Stock
April 12, 2022 16:17 ET
|
Liquidia Corporation
MORRISVILLE, N.C., April 12, 2022 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) (“Liquidia”) announced today that it has commenced an underwritten public offering of its common stock. All...
Liquidia Corporation Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
March 22, 2022 16:30 ET
|
Liquidia Corporation
MORRISVILLE, N.C., March 22, 2022 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) today announced the grant of an inducement stock option exercisable for an aggregate of 2,000 shares of...
Liquidia Corporation Reports Full-Year 2021 Financial Results and Provides Corporate Update
March 17, 2022 06:30 ET
|
Liquidia Corporation
- Received tentative FDA approval of YUTREPIA™ (treprostinil) inhalation powder - Expanded use of Treprostinil Injection to include subcutaneous administration - Preparing to launch YUTREPIA in...
Liquidia Corporation to Report Full Year 2021 Financial Results on Thursday, March 17, 2022
March 10, 2022 07:00 ET
|
Liquidia Corporation
MORRISVILLE, N.C., March 10, 2022 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today that it will report its full year 2021 financial results on Thursday, March 17, 2022. The...